Original Research ArticleInternational Journal of Basic & Clinical Pharmacology

Publication:
Vitamin D3 augments the antidepressant effect of agomelatine against repeated corticosterone-induced depressive-like behavior in rats

Int J Basic Clin Pharmacol. 2021;10(1):10-17.DOI10.18203/2319-2003.ijbcp20205532

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Background Depression is a highly complex psychiatric disorder that remains a major burden on society. The present study was aimed to detect the neuroprotective effect of agomelatine or/and vitamin D3 on the progression of depression induced by chronic administration of corticosterone.

Methods Rats were classified into 4 equal groups; corticosterone-untreated group, agomelatine-treated group, vitamin D3-treated group, and (agomelatine and vitamin D3)-treated group.

Results Agomelatine or/and vitamin D3 caused significant improvement of behavioral parameters of depression, increase in serotonin, dopamine, and brain-derived neurotrophic factor (BDNF) with a significant decrease in tumor necrosis factor (TNF)-alpha and caspase-3 levels of brain tissue with a more significant effect of combination therapy over the effect of each drug alone.

Conclusions Vitamin D3 augments the antidepressant effect of agomelatine against depressive-like behavior in rats.

Keywords

Affiliations

  1. Department of Clinical Pharmacology, Faculty of Medicine, Benha University, Egypt

Full item record